Outsourcing

Mar 01, 2017
BioPharm International
Moving global manufacturing operations may be more complicated than it appears.
Feb 01, 2017
BioPharm International
The outlook for the CMO and CDMO industry may be affected by ever-changing politics.
Jan 25, 2017
By BioPharm International Editors
Vetter expanded visual inspection facilities and controlled-temperature storage at its Ravensburg Vetter West facility in Germany.
Jan 25, 2017
By BioPharm International Editors
SGS invested in test equipment for analyzing extractables and leachables at its New Jersey laboratory.
Jan 09, 2017
The partnership will focus on providing practical information to clients on the development of biologics and vaccines.
Jan 01, 2017
BioPharm International
Robust venture capital investment gives CDMOs and CROs a positive outlook for 2017.
Dec 21, 2016
By BioPharm International Editors
AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.
Dec 01, 2016
BioPharm International
Biosimilars may be the key to CMO growth.
Nov 17, 2016
By BioPharm International Editors
Avecia is adding drug substance capacity at its Milford, MA manufacturing site.
Nov 01, 2016
BioPharm International
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
native1_300x100
lorem ipsum